| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,279,343 ) |
| | 2023 | 2023 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R18HS029283 | Augmenting the On-scene Medic (ATOM): Development of a head-mounted display application to reduce prehospital pediatric medication errors | 000 | 1 | AHRQ | 3/20/2023 | $500,000 |
| | 2023 | 2023 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI142004 | Human B1-like Cells and Pneumococcal Defense in the Elderly | 000 | 5 | NIH | 1/4/2023 | $377,500 |
| | 2023 | 2023 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 Oakland Dr | Kalamazoo | MI | 49008-1282 | KALAMAZOO | USA | TA248957 | Primary Care Training and Enhancement - Residency Training in Mental and Behavioral Health | 00 | 1 | HRSA | 12/21/2022 | $496,202 |
| | 2023 | 2021 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI155775 | Chromatin looping directed RAG targeting during V(D)J recombination | 001 | 1 | NIH | 3/29/2023 | -$94,359 |
|
| Issue Date FY: 2022 ( Subtotal = $1,244,559 ) |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21NS121737 | FAIM Proteostasis in ALS | 000 | 1 | NIH | 5/23/2022 | $415,250 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI154539 | Sex Determines Age-related Changes in the Repertoire and Function of Natural Antibodies Protective against Streptococcus pneumoniae with Increasing Age | 000 | 3 | NIH | 8/22/2022 | $38,000 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI154539 | Sex Determines Age-related Changes in the Repertoire and Function of Natural Antibodies Protective against Streptococcus pneumoniae with Increasing Age | 000 | 3 | NIH | 8/22/2022 | $339,500 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI142004 | Human B1-like Cells and Pneumococcal Defense in the Elderly | 000 | 4 | NIH | 1/21/2022 | $377,500 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI155775 | Chromatin looping directed RAG targeting during V(D)J recombination | 001 | 2 | NIH | 8/29/2022 | -$377,500 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI155775 | Chromatin looping directed RAG targeting during V(D)J recombination | 000 | 2 | NIH | 11/10/2021 | $377,500 |
| | 2022 | 2022 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R03AG072148 | Understanding the link between FAIM expression and Alzheimer?s disease and related dementias | 000 | 2 | NIH | 4/4/2022 | $75,500 |
| | 2022 | 2019 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI029690 | Aberrant Signaling in B1 Cells | 000 | 28 | NIH | 12/7/2021 | $0 |
| | 2022 | 2019 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK119864 | Guanine-quadruplex DNA and polycystic kidney disease | 000 | 1 | NIH | 9/14/2022 | $0 |
| | 2022 | 2018 | Western Michigan University Homer Stryker M.D. School Of Medicine. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | H3430235 | EMSC Targeted Issue Grants | 04 | 3 | HRSA | 5/18/2022 | -$1,191 |
|
| Issue Date FY: 2021 ( Subtotal = $1,208,000 ) |
| | 2021 | 2021 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R03AG072148 | Understanding the link between FAIM expression and Alzheimer?s disease and related dementias | 000 | 1 | NIH | 3/30/2021 | $75,500 |
| | 2021 | 2021 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI142004 | Human B1-like Cells and Pneumococcal Defense in the Elderly | 000 | 3 | NIH | 1/19/2021 | $377,500 |
| | 2021 | 2021 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI154539 | Sex Determines Age-related Changes in the Repertoire and Function of Natural Antibodies Protective against Streptococcus pneumoniae with Increasing Age | 000 | 2 | NIH | 8/16/2021 | $377,500 |
| | 2021 | 2021 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI155775 | Chromatin looping directed RAG targeting during V(D)J recombination | 000 | 1 | NIH | 12/1/2020 | $377,500 |
| | 2021 | 2018 | WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE. | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AI128464 | Reprogramming BCR Signaling | 000 | 2 | NIH | 12/21/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $755,000 ) |
| | 2020 | 2020 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI154539 | Sex Determines Age-related Changes in the Repertoire and Function of Natural Antibodies Protective against Streptococcus pneumoniae with Increasing Age | 000 | 1 | NIH | 9/21/2020 | $339,500 |
| | 2020 | 2020 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI154539 | Sex Determines Age-related Changes in the Repertoire and Function of Natural Antibodies Protective against Streptococcus pneumoniae with Increasing Age | 000 | 1 | NIH | 9/21/2020 | $38,000 |
| | 2020 | 2020 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI142004 | Human B1-like Cells and Pneumococcal Defense in the Elderly | 000 | 2 | NIH | 2/6/2020 | $377,500 |
| | 2020 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK119864 | Guanine-quadruplex DNA and polycystic kidney disease | 000 | 1 | NIH | 7/8/2020 | -$339,750 |
| | 2020 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK119864 | Guanine-quadruplex DNA and polycystic kidney disease | 001 | 1 | NIH | 7/14/2020 | $339,750 |
|
| Issue Date FY: 2019 ( Subtotal = $1,065,151 ) |
| | 2019 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI029690 | Aberrant Signaling in B1 Cells | 000 | 28 | NIH | 4/12/2019 | $377,500 |
| | 2019 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI142004 | Human B1-like Cells and Pneumococcal Defense in the Elderly | 000 | 1 | NIH | 1/31/2019 | $377,500 |
| | 2019 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK119864 | Guanine-quadruplex DNA and polycystic kidney disease | 000 | 1 | NIH | 8/29/2019 | $339,750 |
| | 2019 | 2019 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK119864 | Guanine-quadruplex DNA and polycystic kidney disease | 001 | 1 | NIH | 8/30/2019 | $0 |
| | 2019 | 2018 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | H3430235 | EMSC Targeted Issue Grants | 03 | 3 | HRSA | 8/19/2019 | $0 |
| | 2019 | 2018 | Western Michigan University School Of Medicine | 1000 Oakland Dr | Kalamazoo | MI | 49008-1282 | KALAMAZOO | USA | H3430235 | EMSC Targeted Issue Grants | 01 | 3 | HRSA | 4/30/2019 | $0 |
| | 2019 | 2018 | Western Michigan University School Of Medicine | 1000 Oakland Dr | Kalamazoo | MI | 49008-1282 | KALAMAZOO | USA | H3430235 | EMSC Targeted Issue Grants | 02 | 3 | HRSA | 8/14/2019 | $0 |
| | 2019 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AI126336 | IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100 | 000 | 3 | NIH | 1/8/2019 | $0 |
| | 2019 | 2016 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AG050849 | Tau-binding B Cells in Alzheimer's Disease | 000 | 3 | NIH | 8/22/2019 | -$29,599 |
| | 2019 | 2014 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK100972 | Cux1 and cell cycle regulation in kidney development and disease | 002 | 2 | NIH | 3/25/2019 | -$32 |
| | 2019 | 2014 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R15DK100972 | Cux1 and cell cycle regulation in kidney development and disease | 001 | 2 | NIH | 3/6/2019 | $32 |
|
| Issue Date FY: 2018 ( Subtotal = $879,000 ) |
| | 2018 | 2018 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R01AI029690 | Aberrant Signaling in B1 Cells | 000 | 27 | NIH | 4/27/2018 | $377,500 |
| | 2018 | 2018 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AI128464 | Reprogramming BCR Signaling | 000 | 2 | NIH | 6/22/2018 | $226,500 |
| | 2018 | 2018 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | H34MC30235 | EMSC Targeted Issue Grants | 00 | 3 | HRSA | 7/13/2018 | $275,000 |
| | 2018 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | H34MC30235 | EMSC Targeted Issue Grants | 01 | 2 | HRSA | 4/6/2018 | $0 |
| | 2018 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R03AI123875 | B1a Cell Function in Sickle Cell Disease | 000 | 3 | NIH | 5/7/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $2,075,853 ) (Continued on the next page) |
| | 2017 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | H34MC30235 | EMSC Targeted Issue Grants | 00 | 2 | HRSA | 7/20/2017 | $275,000 |
| | 2017 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AI128464 | Reprogramming BCR Signaling | 000 | 1 | NIH | 7/17/2017 | $188,750 |
| | 2017 | 2017 | WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE | 1000 OAKLAND DR | KALAMAZOO | MI | 49008-1282 | KALAMAZOO | USA | R21AI126336 | IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100 | 002 | 3 | NIH | 6/14/2017 | $226,500 |
|
